Literature DB >> 26109676

No Benefit to Delaying Pneumococcal Polysaccharide Vaccination in HIV-Positive Adults.

David J Leggat1, Anita S Iyer1, M A Julie Westerink2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26109676      PMCID： PMC4633768          DOI： 10.1093/infdis/jiv349

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

1.  Recommended adult immunization schedule: United States, October 2007-September 2008.

Authors: 
Journal:  Ann Intern Med       Date:  2007-10-18       Impact factor: 25.391

2.  Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.

Authors:  Saeyoung Park; Moon H Nahm
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells.

Authors:  David J Leggat; Rebecca S Thompson; Noor M Khaskhely; Anita S Iyer; M A Julie Westerink
Journal:  J Infect Dis       Date:  2013-04-01       Impact factor: 5.226

4.  Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

Authors:  Kehmia Titanji; Angelo De Milito; Alberto Cagigi; Rigmor Thorstensson; Sven Grützmeier; Ann Atlas; Bo Hejdeman; Frank P Kroon; Lucia Lopalco; Anna Nilsson; Francesca Chiodi
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

5.  Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial.

Authors:  Maria C Rodriguez-Barradas; Jose A Serpa; Iona Munjal; Daniel Mendoza; Adriana M Rueda; Mahwish Mushtaq; Liise-Anne Pirofski
Journal:  J Infect Dis       Date:  2014-12-23       Impact factor: 5.226

6.  Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Jonathan E Kaplan; Constance Benson; King K Holmes; John T Brooks; Alice Pau; Henry Masur
Journal:  MMWR Recomm Rep       Date:  2009-04-10

Review 7.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

8.  Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals.

Authors:  David J Leggat; Anita S Iyer; Jennifer A Ohtola; Sneha Kommoori; Joan M Duggan; Claudiu A Georgescu; Sadik A Khuder; Noor M Khaskhely; Ma Julie Westerink
Journal:  J AIDS Clin Res       Date:  2015-02

9.  Response to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy.

Authors:  Anita S Iyer; David J Leggat; Jennifer A Ohtola; Joan M Duggan; Claudiu A Georgescu; Adeeb A Al Rizaiza; Sadik A Khuder; Noor M Khaskhely; Julie Westerink
Journal:  J AIDS Clin Res       Date:  2015-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.